Latest filing published 22 Mar 2021 for VistaGen Therapeutics, Inc., €3,146.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +324.3%Entry US$21.00 · Close at T+365 US$89.10
- -74.0%Entry US$38.10 · Close at T+365 US$9.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jon S. Saxe: trading record in brief
Jon S. Saxe is a declared insider at 6 companies; the most frequent names are Durect Corp, PDL Biopharma, Inc. and Sciclone Pharmaceuticals Inc. The record holds 160 filings, for trades running from 4 January 2006 to 19 March 2021.
Market trades split into 113 purchases (€169k) and 22 sales (€2.5M). Netting one side against the other leaves €2.4M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants and 20 option exercises.
A typical purchase (the median) is worth €434. Clusters matter here: 42 out of 101 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -38.6%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 22 March 2021: an option exercise of €3,146, in VistaGen Therapeutics, Inc. The most recent open-market purchase was published on 24 August 2020, 2,267 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jon S. Saxe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$1.507.0% of flowCommon StockSEC:0001415889-21-001607:0
- 30,000 shares@ US$0.69100.0% of flowCommon StockSEC:0001415889-20-002181:0Canonical exit: 19 Nov 2020 (T+90)
- 287 shares@ US$0.54280.2% of flowCommon StockSEC:0001082038-19-000015:0Canonical exit: 8 Sept 2019 (T+90)
- 1,200 shares@ US$0.54380.7% of flowCommon StockSEC:0001082038-19-000015:1Canonical exit: 8 Sept 2019 (T+90)
- 200 shares@ US$0.54390.1% of flowCommon StockSEC:0001082038-19-000015:2Canonical exit: 8 Sept 2019 (T+90)
- 15 shares@ US$0.5440.0% of flowCommon StockSEC:0001082038-19-000015:3Canonical exit: 8 Sept 2019 (T+90)
- 300 shares@ US$0.54430.2% of flowCommon StockSEC:0001082038-19-000015:4Canonical exit: 8 Sept 2019 (T+90)
- 100 shares@ US$0.54440.1% of flowCommon StockSEC:0001082038-19-000015:5Canonical exit: 8 Sept 2019 (T+90)
- 7,898 shares@ US$0.54494.9% of flowCommon StockSEC:0001082038-19-000015:6Canonical exit: 8 Sept 2019 (T+90)
- 100 shares@ US$0.54510.1% of flowCommon StockSEC:0001082038-19-000015:7Canonical exit: 8 Sept 2019 (T+90)
- 1,751 shares@ US$0.54541.1% of flowCommon StockSEC:0001082038-19-000015:8Canonical exit: 8 Sept 2019 (T+90)
- 300 shares@ US$0.54550.2% of flowCommon StockSEC:0001082038-19-000015:9Canonical exit: 8 Sept 2019 (T+90)
- 1,400 shares@ US$0.54590.9% of flowCommon StockSEC:0001082038-19-000015:10Canonical exit: 8 Sept 2019 (T+90)
- 500 shares@ US$0.54990.3% of flowCommon StockSEC:0001082038-19-000015:11Canonical exit: 8 Sept 2019 (T+90)
- 300 shares@ US$0.550.2% of flowCommon StockSEC:0001082038-19-000015:12Canonical exit: 8 Sept 2019 (T+90)
- 1,800 shares@ US$0.55191.1% of flowCommon StockSEC:0001082038-19-000015:13Canonical exit: 8 Sept 2019 (T+90)
- 400 shares@ US$0.55280.2% of flowCommon StockSEC:0001082038-19-000015:14Canonical exit: 8 Sept 2019 (T+90)
- 1,400 shares@ US$0.55370.9% of flowCommon StockSEC:0001082038-19-000015:15Canonical exit: 8 Sept 2019 (T+90)
- 3,449 shares@ US$0.55732.2% of flowCommon StockSEC:0001082038-19-000015:16Canonical exit: 8 Sept 2019 (T+90)
- 626 shares@ US$0.55880.4% of flowCommon StockSEC:0001082038-19-000015:17Canonical exit: 8 Sept 2019 (T+90)
- 74 shares@ US$0.5590.0% of flowCommon StockSEC:0001082038-19-000015:18Canonical exit: 8 Sept 2019 (T+90)
- 2,900 shares@ US$0.55961.8% of flowCommon StockSEC:0001082038-19-000015:19Canonical exit: 8 Sept 2019 (T+90)
- 4,065 shares@ US$0.632.9% of flowCommon StockSEC:0001082038-19-000014:0Canonical exit: 22 Aug 2019 (T+90)
- 21,335 shares@ US$0.630115.4% of flowCommon StockSEC:0001082038-19-000014:1Canonical exit: 22 Aug 2019 (T+90)
- 4,600 shares@ US$0.63023.3% of flowCommon StockSEC:0001082038-19-000014:2Canonical exit: 22 Aug 2019 (T+90)
25 of 158 declarations
